GlassScriptPhysician profile
Aaron R Braun
NPI 1821251083
$23,400.56
in general payments reported to CMS, 2019-2025
38 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $47.21 · 2021: $6,132 · 2022: $4,513 · 2023: $468 · 2024: $143 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $8,562 · Food and Beverage: $1,997 · Travel and Lodging: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $8,562.15 |
| Food and Beverage | $1,996.75 |
| Travel and Lodging | $789.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $9,597.10 | 2019-2025 | Powerflow, Lutonix Drug Coated Balloon, Powerport M.R.I. Implantable Port |
| Becton, Dickinson and Company | $9,351.96 | 2025 | |
| Penumbra, INC. | $649.33 | 2019-2023 | Indigo System |
| Balt USA, LLC | $544.31 | 2021-2023 | Prestige Coil System |
| Terumo Medical Corporation | $410.84 | 2019-2023 | Azur Cx Detachable, Glidewire |
| Inari Medical, INC. | $363.31 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Siemens Medical Solutions USA, INC. | $331.14 | 2019-2025 | Cryocare Cs, Microthermx Microwave Ablation System |
| Sirtex Medical INC | $302.47 | 2019-2025 | Sir-Spheres Microspheres |
| Medtronic, INC. | $250.48 | 2021-2022 | |
| Tenex Health INC. | $250.18 | 2021 | |
| Angiodynamics, INC. | $238.67 | 2021-2025 | Solero, Micro Access |
| Boston Scientific Corporation | $221.45 | 2019-2025 | Emblem Mri S-Icd |
| Avinger INC. | $117.71 | 2019 | |
| Teleflex LLC | $110.88 | 2025 | Arrow |
| Stryker Corporation | $82.93 | 2020-2023 | Ortholoc 3di, Fixos, Augment Injectable |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $42.61 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Davol INC. | $40.18 | 2023-2024 | Trek |
| Leica Microsystems INC. | $38.63 | 2021-2022 | |
| Abbott Laboratories | $38.40 | 2019-2021 | |
| Genentech USA, INC. | $38.31 | 2025 | Polivy, Tecentriq |
| Novartis Pharmaceuticals Corporation | $36.37 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $35.01 | 2025 | Lynozyfic |
| Servier Pharmaceuticals LLC | $32.60 | 2025 | |
| Genmab U.S., INC. | $31.60 | 2025 | Epkinly |
| Nevro Corp. | $31.12 | 2024 | Senza |
| Trisalus Life Sciences, INC. | $28.02 | 2025 | Trinav Infusion System |
| Rigel Pharmaceuticals, INC. | $24.07 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $22.15 | 2025 | Ultomiris |
| W. L. Gore & Associates, INC. | $19.10 | 2020 | |
| Janssen Biotech, INC. | $17.83 | 2025 | Rybrevant |
| Coherus Oncology, INC. | $15.03 | 2025 | Loqtorzi |
| Incyte Corporation | $14.22 | 2025 | Monjuvi, Zynyz |
| Stemline Therapeutics INC. | $14.00 | 2024 | Orserdu |
| Intera Oncology, INC | $13.96 | 2025 | Intera |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2025 | Tagrisso |
| Eisai INC. | $13.15 | 2024 | |
| Pacira Therapeutics, INC. | $10.96 | 2019 | |
| Pharmaand Gmbh | $6.59 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.